JP2001510794A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2001510794A5 JP2001510794A5 JP2000503830A JP2000503830A JP2001510794A5 JP 2001510794 A5 JP2001510794 A5 JP 2001510794A5 JP 2000503830 A JP2000503830 A JP 2000503830A JP 2000503830 A JP2000503830 A JP 2000503830A JP 2001510794 A5 JP2001510794 A5 JP 2001510794A5
- Authority
- JP
- Japan
- Prior art keywords
- surgery
- composition
- levobupivacaine
- motor block
- hours
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9715322.5 | 1997-07-21 | ||
| GB9715322A GB9715322D0 (en) | 1997-07-21 | 1997-07-21 | Levobupivacaine and its use |
| GBGB9722023.0A GB9722023D0 (en) | 1997-10-17 | 1997-10-17 | Levobupivacaine and its use |
| GB9722023.0 | 1997-10-17 | ||
| PCT/GB1998/002169 WO1999004771A2 (en) | 1997-07-21 | 1998-07-21 | Use of levobupivacaine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2001510794A JP2001510794A (ja) | 2001-08-07 |
| JP2001510794A5 true JP2001510794A5 (https=) | 2006-01-05 |
Family
ID=26311915
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000503830A Pending JP2001510794A (ja) | 1997-07-21 | 1998-07-21 | レボブピバカインとその使用 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US5945435A (https=) |
| EP (1) | EP0998286A2 (https=) |
| JP (1) | JP2001510794A (https=) |
| AU (1) | AU742488B2 (https=) |
| BR (1) | BR9802536A (https=) |
| CA (1) | CA2294950C (https=) |
| WO (1) | WO1999004771A2 (https=) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU752802C (en) | 1997-11-14 | 2006-04-13 | Pacira Pharmaceuticals, Inc. | Production of multivesicular liposomes |
| IL140899A0 (en) | 1998-07-17 | 2002-02-10 | Skyepharma Inc | Lipid/polymer containing pharmaceutical compositions and processes for the preparation thereof |
| US6520949B2 (en) * | 2001-04-02 | 2003-02-18 | Martin St. Germain | Method and apparatus for administering fluid to animals subcutaneously |
| AU2002322024B2 (en) * | 2001-05-31 | 2008-05-08 | Pacira Pharmaceuticals, Inc. | Encapsulation of nanosuspensions in liposomes and microspheres |
| US11033495B1 (en) | 2021-01-22 | 2021-06-15 | Pacira Pharmaceuticals, Inc. | Manufacturing of bupivacaine multivesicular liposomes |
| US12151024B2 (en) | 2021-01-22 | 2024-11-26 | Pacira Pharmaceuticals, Inc. | Manufacturing of bupivacaine multivesicular liposomes |
| US11357727B1 (en) | 2021-01-22 | 2022-06-14 | Pacira Pharmaceuticals, Inc. | Manufacturing of bupivacaine multivesicular liposomes |
| US11278494B1 (en) | 2021-01-22 | 2022-03-22 | Pacira Pharmaceuticals, Inc. | Manufacturing of bupivacaine multivesicular liposomes |
| EP4415713A4 (en) | 2021-10-14 | 2025-08-06 | Pacira Pharmaceuticals Inc | MULTIVESICULAR LIPOSOME FORMULATIONS OF BUPIVACAINE AND THEIR USES |
| CN119677554A (zh) | 2022-05-05 | 2025-03-21 | 普络夫有限责任公司 | 麻醉神经阻滞和方法 |
| US12070454B1 (en) | 2022-05-05 | 2024-08-27 | Pfof Llc | Anesthetic nerve block and method |
| US12251472B1 (en) | 2024-05-20 | 2025-03-18 | Pacira Pharmaceuticals, Inc. | Manufacturing of bupivacaine multivesicular liposomes |
| US12156940B1 (en) | 2024-05-20 | 2024-12-03 | Pacira Pharmaceuticals, Inc. | Manufacturing of bupivacaine multivesicular liposomes |
| US12280149B1 (en) | 2024-05-20 | 2025-04-22 | Pacira Pharmaceuticals, Inc. | Manufacturing of bupivacaine multivesicular liposomes |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4695576A (en) * | 1984-07-09 | 1987-09-22 | Astra Lake Medel Aktiebolag | L-N-n-propylpipecolic acid-2,6-xylidide |
| SE9302218D0 (sv) * | 1993-06-28 | 1993-06-28 | Ab Astra | New use |
| EP0727210B1 (en) * | 1993-10-13 | 2001-12-19 | Darwin Discovery Limited | Analgesic agent and its use |
| AU704806B2 (en) * | 1995-04-13 | 1999-05-06 | Darwin Discovery Limited | Levobupivacaine and its use as an anaesthetic in pregnant women |
| GB9704352D0 (en) * | 1997-03-03 | 1997-04-23 | Chiroscience Ltd | Levobupivacaine and its use |
-
1998
- 1998-07-21 WO PCT/GB1998/002169 patent/WO1999004771A2/en not_active Ceased
- 1998-07-21 US US09/119,910 patent/US5945435A/en not_active Expired - Lifetime
- 1998-07-21 AU AU84527/98A patent/AU742488B2/en not_active Expired
- 1998-07-21 EP EP98935175A patent/EP0998286A2/en not_active Withdrawn
- 1998-07-21 JP JP2000503830A patent/JP2001510794A/ja active Pending
- 1998-07-21 BR BR9802536A patent/BR9802536A/pt not_active Application Discontinuation
- 1998-07-21 CA CA002294950A patent/CA2294950C/en not_active Expired - Lifetime
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4604384A (en) | Pharmaceutical gel composition | |
| JP2001510794A5 (https=) | ||
| JP2001510795A5 (https=) | ||
| IL139231A0 (en) | Preparations for the application of anti-inflammatory, especially antiseptic, agents and/or agents promoting the healing of wounds to the lower respiratory tract | |
| ID24901A (id) | Metode pengobatan keadaan terkoagulasi tinggi atau defisiensi protein c yang diperoleh | |
| JPH11506017A5 (https=) | ||
| JP2002532432A5 (https=) | ||
| DE59607342D1 (de) | Verwendung von Prolin als einziger therapeutischer Wirkstoff zur Herstellung eines Arzneimittels zur Behandlung von rheumatischen Erkrankungen und von chronischen und traumatisch bedingten Schmerzzuständen | |
| DE69521536D1 (de) | Zusammensetzungen die G-CSF und ein TNF-Bindungsprotein enthalten | |
| CA2274686A1 (en) | Sulfonic acid or sulfonylamino n-(heteroaralkyl)-azaheterocyclylamide compounds | |
| DE69327328D1 (de) | Verwendund von norastemizol zur behandlung der allergischen rhinitis | |
| Butler et al. | Bupivacaine and Kaltostat reduces post-operative donor site pain | |
| WO2001089537A3 (en) | Apoptotic entities for use in treatment of neurodegenerative and other neurological disorders | |
| WO1999004771A3 (en) | Use of levobupivacaine | |
| US5278172A (en) | Method and composition for treating tendon or joint inflammation using a vasodilator | |
| CA2627223C (en) | Wound-healing pharmaceutical compositions in the form of a sterile powder based on amino acids and sodium hyaluronate | |
| CN1116048C (zh) | 治疗烧烫伤外用浸膏及制备方法 | |
| ES2182840T3 (es) | Factor xiii para el tratamiento de heridas de la piel. | |
| RU2082396C1 (ru) | Способ противоишемической защиты тканей конечности при операциях и травмах опорно-двигательной системы | |
| EP1632235A3 (en) | Use of highly selective norepinephrine reuptake inhibitors for the treatment of mental disorders | |
| AU558482B2 (en) | Pharmaceutical gel composition | |
| Tecuceanu et al. | The Particularities of Using Enzymatic Debridement Therapy in Deep Burns Treatment According to Functional Regions | |
| CA1300505C (en) | Amelioration or elimination of postoperative pain | |
| CN1110316C (zh) | 一种黑膏药及制备工艺 | |
| Krizek | Wound and reconstructive problems in advanced disease |